Seeing Is Believing
Currently out of the existing stock ratings of Lucas Lee, 2 are a HOLD (50%), 2 are a BUY (50%).
Analyst Lucas Lee, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 100% that have a potential upside of 14.86% achieved within 52 days.
Lucas Lee’s has documented 6 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ZTS, Zoetis at 16-Jul-2021.
Analyst best performing recommendations are on ZTS (ZOETIS).
The best stock recommendation documented was for ZTS (ZOETIS) at 3/8/2021. The price target of $166 was fulfilled within 43 days with a profit of $23.12 (16.18%) receiving and performance score of 3.76.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$230
$54.75 (31.24%)
$225
1 months 22 days ago
(11-Oct-2024)
1/3 (33.33%)
$39.92 (21.00%)
200
Buy
$210
$34.75 (19.83%)
$200
2 months 15 days ago
(18-Sep-2024)
12/21 (57.14%)
$13.52 (6.88%)
163
Buy
$210
$34.75 (19.83%)
$220
3 months 19 days ago
(14-Aug-2024)
2/8 (25%)
$26.62 (14.52%)
152
Buy
$196
$20.75 (11.84%)
$226
6 months 27 days ago
(06-May-2024)
4/7 (57.14%)
$30.05 (18.11%)
218
Buy
$230
$54.75 (31.24%)
$260
7 months 10 days ago
(23-Apr-2024)
7/11 (63.64%)
$80.44 (53.78%)
129
What Year was the first public recommendation made by Lucas Lee?